MAP kinases, Rho‐GTPase and PI3K/AKT/p70S6K/MAPK are the main contributors to targeted therapy‐induced CRC toxicity, causing phytochemicals’ antioxidant activity to inhibit cancer cell proliferation 21. The gene discussed is AKT1; the disease is colorectal carcinoma.